Clinical efficacy of combination therapy of an immune checkpoint inhibitor with taxane plus platinum versus an immune checkpoint inhibitor with fluorouracil plus platinum in the first-line treatment of patients with locally advanced, metastatic, or recurrent esophageal squamous cell carcinoma

Clinical efficacy of combination therapy of an immune checkpoint inhibitor with taxane plus platinum versus an immune checkpoint inhibitor with fluorouracil plus platinum in the first-line treatment of patients with locally advanced, metastatic, or recurrent esophageal squamous cell carcinoma

BackgroundChemotherapy combined with immune checkpoints inhibitors (ICIs) has been established as a standard treatment for locally advanced, metastatic, or recurrent esophageal squamous cell cancer (ESCC). However, the optimal chemotherapy regimen in combination therapy is still unclear.PurposeTo in...

Full description

Bibliographic Details
Main Authors: Ying Li, Yanyan Ji, Lin Shen, Xudong Yin, Tianyu Huang, Bin Deng, Hong Guo, Yunjiang Wu, Yong Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
esophageal squamous cell cancer
first-line therapy
immune checkpoint inhibitors
immunotherapy
chemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1015302/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1015302/full

Similar Items